Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for MDX.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 -10.70M
March 31, 2026 -9.430M
December 31, 2025 -9.739M
September 30, 2025 -10.02M
June 30, 2025 -8.792M
March 31, 2025 -9.507M
December 31, 2024 -8.524M
September 30, 2024 -8.972M
June 30, 2024 -8.368M
March 31, 2024 -8.004M
December 31, 2023 -7.142M
September 30, 2023 -7.681M
June 30, 2023 -7.310M
March 31, 2023 -6.293M
December 31, 2022 -7.081M
September 30, 2022 -6.089M
June 30, 2022 -5.352M
March 31, 2022 -4.150M
December 31, 2021 -3.630M
September 30, 2021 -3.720M
June 30, 2021 -2.414M
March 31, 2021 -2.289M
December 31, 2020 -2.070M
September 30, 2020 -1.410M
June 30, 2020 -0.931M
Date Value
March 31, 2020 -1.931M
December 31, 2019 -2.867M
September 30, 2019 -2.462M
June 30, 2019 -2.097M
March 31, 2019 -1.784M
December 31, 2018 -1.544M
September 30, 2018 -1.134M
June 30, 2018 -0.7135M
March 31, 2018 -0.2742M
December 31, 2017 -1.729M
September 30, 2017 -2.153M
June 30, 2017 -1.910M
March 31, 2017 -2.295M
December 31, 2016 -2.052M
September 30, 2016 -1.798M
June 30, 2016 -2.363M
March 31, 2016 -2.587M
December 31, 2015 -2.392M
September 30, 2015 -2.489M
June 30, 2015 -2.274M
March 31, 2015 -2.265M
December 31, 2014 -2.261M
September 30, 2014 -2.331M
June 30, 2014 -2.674M
March 31, 2014 -3.165M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
MedMira, Inc. -24.52M
VentriPoint Diagnostics Ltd. -4.117M
Theralase Technologies, Inc. 1.950M
Profound Medical Corp. 70.67M
VVT Med, Inc. -3.26M

Shareholders Equity (Quarterly) Related Metrics